Drury M Stith, M.D. Internal Medicine - Medical Oncology Medicare: Medicare Enrolled Practice Location: 10085 William F. Bernart Circle, Nassawadox, VA 23413 Phone: 757-414-8355 Fax: 757-414-8016 |
James Lund Mcdaniel, MD Internal Medicine - Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 9524 Hospital Ave, Nassawadox, VA 23413 Phone: 757-442-6600 Fax: 757-442-3839 |
Vincent Joseph Stravino, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 9507 Hospital Avenue, Nassawadox, VA 23413 Phone: 757-414-8000 Fax: 757-414-8618 |
Laura Diane Kerbin, M.D. Internal Medicine - Medical Oncology Medicare: Accepting Medicare Assignments Practice Location: 10085 William F Bernart Circle, Nassawadox, VA 23413 Phone: 757-414-8355 Fax: 757-414-8016 |
Lloyd Joseph Kellam Iii, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 9524 Hospital Ave, Nassawadox, VA 23413 Phone: 757-442-6600 Fax: 757-442-3839 |
David Jay Klein, MD Internal Medicine - Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 10085 William F. Bernart Circle, Nassawadox, VA 23413 Phone: 757-414-8355 Fax: 757-414-8016 |
News Archive
People who are witnessed by a bed partner to have stopped breathing during sleep may have higher accumulations of an Alzheimer's disease biomarker called tau in an area of the brain that helps with memory, according to a preliminary study released today that will be presented at the American Academy of Neurology's 71st Annual Meeting in Philadelphia, May 4 to 10, 2019.
Exposure to the fumes emitted from solvents and cleaning products at home may increase the risk of childhood asthma, suggests a study by Australian researchers from Curtin University and the University of Sydney.
Women with polycystic ovary syndrome, the most common hormone condition among young women, are prone to mental health disorders, and their children face an increased risk of developing attention deficit hyperactivity disorder and autism spectrum disorder, according to a new study published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism.
Vanda Pharmaceuticals Inc., a biopharmaceutical company focused on the development and commercialization of products for central nervous system disorders, today announced financial and operational results for the third quarter and nine months ended September 30, 2010.
› Verified 7 days ago